We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RVSB:NASDAQRiverview Bancorp Inc Analysis

Data as of 2026-04-29 - not real-time

$5.35

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Riverview Bancorp is trading at $5.35, well below its DCF‑derived fair value of $7.36, implying roughly a 30% upside. The stock sits above its 20‑day SMA (5.52) and 50‑day SMA (5.41) and the longer‑term 200‑day SMA (5.25), a classic bullish alignment, while price remains just above the technical support at $5.27 and below the resistance near $5.84. Momentum indicators are mixed – the RSI at 43 suggests neutral pressure and the MACD histogram is negative, but the overall trend direction is flagged as bullish and volume is stable.
Fundamentally, RVSB posted 9.6% revenue growth, an operating margin of 13.8% and a modest dividend yield of 1.45% with a payout ratio under 35%, supporting dividend sustainability. The company’s beta of 0.56 points to lower market sensitivity, though a 30‑day volatility of 26% and a high debt load relative to cash warrant caution. The combination of undervaluation, steady cash flow, and a modest dividend makes the stock attractive for investors with a medium‑term horizon, while short‑term traders may prefer to wait for clearer price confirmation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with bullish SMA hierarchy
  • Mixed MACD/RSI signals create short‑term uncertainty
  • Stable trading volume supports liquidity

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value indicates ~30% upside
  • Revenue growth of ~10% and solid operating margins
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt relative to cash raises credit risk over time
  • Regulatory environment for regional banks remains uncertain
  • Low beta and consistent dividend support steady returns

Key Metrics & Analysis

Financial Health

Revenue Growth9.60%
Profit Margin9.15%
P/E Ratio23.3
ROE3.01%
ROA0.32%
P/B Ratio0.7
Op. Cash Flow$15.4M
Industry P/E17.5

Technical Analysis

TrendBullish
RSI43.3
Support$5.27
Resistance$5.84
MA 20$5.52
MA 50$5.41
MA 200$5.25
MACDBearish
VolumeStable
Fear & Greed Index89.59

Valuation

Fair Value$7.36
Target Price$7.00
Upside/Downside30.84%
GradeUndervalued
TypeValue
Dividend Yield1.45%

Risk Assessment

Beta0.56
Volatility26.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.